Prevalence and Incidence of HCV Infection among Vietnam Heroin Users with Recent Onset of Injection

被引:0
|
作者
Michael C. Clatts
Vivian Colón-López
Le M. Giang
Lloyd A. Goldsamt
机构
[1] University of Puerto Rico,School of Public Health
[2] Hanoi Medical University,Center for Research and Training on HIV/AIDS
[3] National Development and Research Institutes,Center for Research on Global Health, Graduate School of Public Health
[4] Inc.,undefined
[5] University of Puerto Rico,undefined
[6] Medical Sciences Campus,undefined
来源
Journal of Urban Health | 2010年 / 87卷
关键词
Hepatitis C prevalence; HCV incidence; Onset and initiation of heroin injection; IDU's; Harm reduction; Vietnam;
D O I
暂无
中图分类号
学科分类号
摘要
HCV infection continues to spread at an alarming rate among IDU populations. The available evidence suggests that HCV is acquired relatively quickly following onset of injection. However, there are few prospective studies of HCV acquisition, particularly among IDU populations in resource-poor settings. A sample of young male heroin injectors with recent onset of injection (<4 years) was recruited in Hanoi, Vietnam for a prospective assessment of the early course of injection (n = 179). Both behavioral and biological assessments (including detailed retrospective assessment of injection initiation) were conducted at baseline and repeated at 6-month intervals for a period of 16 months. Variables associated with HCV infection (p value < 0.05) in bivariate analyses were considered for inclusion in logistic regression models to identify risk factors independently associated with HCV infection. HCV incidence was calculated by using the incidence density approach and was expressed in terms of person-years of observation. The baseline of prevalence of HCV was 46%. HCV significantly increased in relation to time since first injection, from 30% in subjects with ≤10 months of injection risk to 70% in subjects with ≥30 months injection risk (p value = 0.0005). In multivariate logistic regression analysis, increasing age, incarceration in a drug detention facility (OR = 2.54; 95%CI 1.05, 6.15), and time since first injection remained significantly associated with HCV infection. Use of injection as primary mode of administration (OR = 2.56; 95%CI 0.98, 6.69) achieved marginal significance. After 16 months of follow-up, the incidence rate of HCV was 23.35 per 100 person-years and the mean time between first injection and first positive HCV test was 1.2 years. HCV is acquired much more rapidly among new injector populations than previously recognized, demonstrating the need for early behavioral intervention among new heroin-user populations. Particularly critical are interventions that target new heroin user populations, including interventions that improve understanding of viral transmission dynamics, that promote alternative strategies for drug sharing, and that delay initiation of injection.
引用
收藏
页码:278 / 291
页数:13
相关论文
共 50 条
  • [31] Declining prevalence of injection as main route of administration among heroin users treated in Spain, 1991-1993
    de la Fuente, L
    Lardelli, P
    Barrio, G
    Vicente, J
    Luna, JD
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 1997, 7 (04): : 421 - 426
  • [32] Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection
    Patrick, DM
    Tyndall, MW
    Cornelisse, PGA
    Li, K
    Sherlock, CH
    Rekart, ML
    Strathdee, SA
    Currie, SL
    Schechter, MT
    O'Shaughnessy, MV
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2001, 165 (07) : 889 - 895
  • [33] Epidemics of HIV, HCV and syphilis infection among synthetic drugs only users, heroin-only users and poly-drug users in Southwest China
    Su, Shu
    Mao, Limin
    Zhao, Jinxian
    Chen, Liang
    Jing, Jun
    Cheng, Feng
    Zhang, Lei
    SCIENTIFIC REPORTS, 2018, 8
  • [34] Epidemics of HIV, HCV and syphilis infection among synthetic drugs only users, heroin-only users and poly-drug users in Southwest China
    Shu Su
    Limin Mao
    Jinxian Zhao
    Liang Chen
    Jun Jing
    Feng Cheng
    Lei Zhang
    Scientific Reports, 8
  • [35] Mortality risk among recent-onset injection drug users in five US Cities
    Vlahov, David
    Wang, Cunlin
    Ompad, Danielle
    Fuller, Crystal M.
    Caceres, Wendy
    Ouellet, Lawrence
    Kerndt, Peter
    Jarlais, Don C. Des
    Garfein, Richard S.
    SUBSTANCE USE & MISUSE, 2008, 43 (3-4) : 413 - 428
  • [36] Factors associated with recent-onset injection drug use among drug users in Pakistan
    Kuo, Irene
    Ul-Hasan, Salman
    Zafar, Tariq
    Galai, Noya
    Sherman, Susan G.
    Strathdee, Steffanie A.
    SUBSTANCE USE & MISUSE, 2007, 42 (05) : 853 - 870
  • [37] High prevalence of latent tuberculosis infection among injection drug users in Tijuana, Mexico
    Garfein, R. S.
    Lozada, R.
    Liu, L.
    Laniado-Laborin, R.
    Rodwell, T. C.
    Deiss, R.
    Alvelais, J.
    Catanzaro, A.
    Chiles, P. G.
    Strathdee, S. A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (05) : 626 - 632
  • [38] Hepatitis C infection among injection drug users in Stockholm Sweden: Prevalence and gender
    Lidman, Christer
    Norden, Lillebil
    Kaberg, Martin
    Kall, Kerstin
    Franck, Johan
    Aleman, Soo
    Birk, Markus
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2009, 41 (09) : 679 - 684
  • [39] Prevalence and correlates of HIV infection among young injection drug users in San Francisco
    Shafer, KP
    Hahn, JA
    Lum, PJ
    Ochoa, K
    Graves, A
    Moss, A
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (04) : 422 - 431
  • [40] HCV Infection Prevalence Lower Than Expected among 18–40-Year-Old Injection Drug Users in San Diego, CA
    Richard S. Garfein
    Amanda Rondinelli
    Richard F. W. Barnes
    Jazmine Cuevas
    Mitcheal Metzner
    Michele Velasquez
    David Rodriguez
    Meredith Reilly
    Jian Xing
    Eyasu H. Teshale
    Journal of Urban Health, 2013, 90 : 516 - 528